chr17-5433172-G-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001212.4(C1QBP):c.700-8C>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00519 in 1,610,432 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001212.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C1QBP | NM_001212.4 | c.700-8C>A | splice_region_variant, intron_variant | ENST00000225698.8 | NP_001203.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C1QBP | ENST00000225698.8 | c.700-8C>A | splice_region_variant, intron_variant | 1 | NM_001212.4 | ENSP00000225698.4 |
Frequencies
GnomAD3 genomes AF: 0.00444 AC: 675AN: 152054Hom.: 4 Cov.: 32
GnomAD3 exomes AF: 0.00482 AC: 1189AN: 246870Hom.: 5 AF XY: 0.00482 AC XY: 645AN XY: 133746
GnomAD4 exome AF: 0.00527 AC: 7692AN: 1458260Hom.: 27 Cov.: 31 AF XY: 0.00527 AC XY: 3823AN XY: 725434
GnomAD4 genome AF: 0.00443 AC: 674AN: 152172Hom.: 4 Cov.: 32 AF XY: 0.00442 AC XY: 329AN XY: 74400
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | C1QBP: BP4, BS2 - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
C1QBP-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 16, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at